Concepedia

Alex Makhnin

AM

Statistics

Publications

10

Citations

469

H-Index

10

Active since

2018

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Molecular Oncology (United States)

Northern Cancer Institute

The University of Sydney

Alex Makhnin is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, medicine, and molecular oncology.

Publications per year

2018–2024

10

Publications

10

Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic <i>EGFR</i>-Mutant Lung Cancers

Helena A. Yu, Adam J. Schoenfeld, Alex Makhnin et al. · JAMA Oncology · 2020 · 131 citations · Full text

Medicine, Oncology, Pharmacology +12

A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers

Joshua K. Sabari, Michael Offin, Dennis Stephens et al. · JNCI Journal of the National Cancer Institute · 2018 · 125 citations · Full text

Medicine, Molecular Medicine, Oncology +17

<i>MET</i> Exon 14–altered Lung Cancers and MET Inhibitor Resistance

Robin Guo, Michael Offin, A. Rose Brannon et al. · Clinical Cancer Research · 2020 · 78 citations · Full text

Medicine, Oncology, Pharmacology +17

Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer

Kamrine E. Poels, Adam J. Schoenfeld, Alex Makhnin et al. · Nature Communications · 2021 · 34 citations · Full text

Medicine, Oncology, Pharmacology +17

A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer

Noura J. Choudhury, W. Victoria Lai, Alex Makhnin et al. · Clinical Cancer Research · 2024 · 28 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 10